Imricor Medical Systems Inc (ASX:IMR) chair and CEO Steve Wedan speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. Full interview can be viewed here.
The company is a leading developer of MRI-compatible medical devices which can be used to carry out MRI-guided cardiac catheter ablation procedures.
Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac catheter ablation procedures.